Malin Corporation | MLC - Current Assets


Malin Corporation reported EUR62.6M in Current Assets for its fiscal semester ending in December of 2024.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
ALKERMES USD 1.52B 164.26M Jun/2026
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Eurofins Scientific SE EUR 2.81B 161M Jun/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Lonza CHF 8B 3.41B Dec/2025
Malin Corporation EUR 62.6M 26.7M Dec/2024
Moderna USD 5.82B 45M Jun/2026
Organon & Co USD 4.93B 580M Mar/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Revvity USD 2.3B 169.4M Jun/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026